Get the full picture
Sign in to uncover key details.
Reglagene
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2450 Holcombe Blvd Ofc, Houston, Texas, ...Website
www.reglagene.comRevenue
<$5 MillionIndustry
About Reglagene
Reglagene is a therapeutics company focused on developing innovative brain penetrant medicines aimed at treating brain diseases, particularly brain cancers. Their lead product is a tubulin-targeting therapy that is orally administered and designed to effectively cross the blood-brain barrier, demonstrating significant tumor growth reduction in preclinical studies. The therapy is characterized by its low molecular weight, allowing it to evade efflux pumps in the brain and maintain its therapeutic action against tumors. Reglagene's intended clients include patients suffering from brain cancers and healthcare providers seeking advanced treatment options.Explore more
Reglagene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Reglagene
Compare insights from companies similar to Reglagene, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Reglagene Tech Stack
A closer look at the technologies used by Reglagene
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Reglagene
Sign Up For FreeTo access detailed company insights
Reglagene is a therapeutics company focused on developing innovative brain penetrant medicines aimed at treating brain diseases, particularly brain cancers. Their lead product is a tubulin-targeting therapy that is orally administered and designed to effectively cross the blood-brain barrier, demonstrating significant tumor growth reduction in prec... Read More
